These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 38759365)

  • 1. Electrophysiological abnormalities of the neuromuscular transmission in two patients with botulism-like syndrome following Botulinum-A muscle injections.
    Theuriet J; Huchon L; Luaute J; Vallet AE; Bouhour F; Pegat A
    Neurophysiol Clin; 2024 Jul; 54(4):102984. PubMed ID: 38759365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Iatrogenic Botulism Outbreak in Egypt due to a Counterfeit Botulinum Toxin A Preparation - A Descriptive Series of Patient Features and Outcome.
    Rashid EAMA; El-Mahdy NM; Kharoub HS; Gouda AS; ElNabarawy NA; Mégarbane B
    Basic Clin Pharmacol Toxicol; 2018 Nov; 123(5):622-627. PubMed ID: 29786953
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Electrophysiological abnormalities in iatrogenic botulism: Two case reports and review of the literature.
    Leonardi L; Haggiag S; Petrucci A; Lispi L
    J Clin Neurosci; 2019 Feb; 60():138-141. PubMed ID: 30348587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Head drop after botox: Electrodiagnostic evaluation of iatrogenic botulinum toxicity.
    Szuch E; Caress JB; Paudyal B; Brashear A; Cartwright MS; Strowd RE
    Clin Neurol Neurosurg; 2017 May; 156():1-3. PubMed ID: 28273554
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delayed Antitoxin Treatment of Two Adult Patients with Botulism after Cosmetic Injection of Botulinum Type A Toxin.
    Fan KL; Wang YL; Chu G; Leung LP
    J Emerg Med; 2016 Dec; 51(6):677-679. PubMed ID: 27687174
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Single-fiber electromyography analysis of botulinum toxin diffusion in patients with fatigue and pseudobotulism.
    Ruet A; Durand MC; Denys P; Lofaso F; Genet F; Schnitzler A
    Arch Phys Med Rehabil; 2015 Jun; 96(6):1103-9. PubMed ID: 25620718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Contralateral Upper Limb Weakness Following Botulinum Toxin A Injection for Poststroke Spasticity.
    Camões-Barbosa A; Ribeiro IM; Medeiros L
    Acta Med Port; 2020 Nov; 33(11):761-764. PubMed ID: 31759399
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Contralateral weakness following botulinum toxin for poststroke spasticity.
    Thomas AM; Simpson DM
    Muscle Nerve; 2012 Sep; 46(3):443-8. PubMed ID: 22907238
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Iatrogenic botulism in an amateur weight-lifter.
    Duffey P; Brown C
    Mov Disord; 2006 Jul; 21(7):1056. PubMed ID: 16639740
    [No Abstract]   [Full Text] [Related]  

  • 10. Effectiveness of botulinum toxin A for upper and lower limb spasticity in children with cerebral palsy: a summary of evidence.
    Lukban MB; Rosales RL; Dressler D
    J Neural Transm (Vienna); 2009 Mar; 116(3):319-31. PubMed ID: 19142573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The broadening application of chemodenervation in X-linked dystonia-parkinsonism (Part II): an open-label experience with botulinum toxin-A (Dysport®) injections for oromandibular, lingual, and truncal-axial dystonias.
    Rosales RL; Ng AR; Santos MM; Fernandez HH
    Int J Neurosci; 2011; 121 Suppl 1():44-56. PubMed ID: 21348790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Generalised botulism-like syndrome after intramuscular injections of botulinum toxin type A: a report of two cases.
    Bakheit AM; Ward CD; McLellan DL
    J Neurol Neurosurg Psychiatry; 1997 Feb; 62(2):198. PubMed ID: 9048725
    [No Abstract]   [Full Text] [Related]  

  • 13. Iatrogenic systemic botulism after intragastric botulinum neurotoxin injection: Case report.
    Kılboz BB; Ervatan Z; Dumlu R; Akan O
    Eur J Neurol; 2023 Oct; 30(10):3394-3396. PubMed ID: 37505930
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and self-reported efficacy of botulinum toxin for adult spasticity in current clinical practice: a prospective observational study.
    Muller F; Cugy E; Ducerf C; Delleci C; Guehl D; Joseph PA; Burbaud P; Dehail P
    Clin Rehabil; 2012 Feb; 26(2):174-9. PubMed ID: 21937525
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Jitter Evaluation in Distant and Adjacent Muscles after Botulinum Neurotoxin Type A Injection in 78 Cases.
    Kouyoumdjian JA; Graça CR; Oliveira FN
    Toxins (Basel); 2020 Aug; 12(9):. PubMed ID: 32867187
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adeno-associated virus transfer of a gene encoding SNAP-25 resistant to botulinum toxin A attenuates neuromuscular paralysis associated with botulism.
    Raghunath A; Perez-Branguli F; Smith L; Dolly JO
    J Neurosci; 2008 Apr; 28(14):3683-8. PubMed ID: 18385326
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal neurophysiological assessment of intramuscular type-A botulin toxin in healthy humans.
    Lispi L; Leonardi L; Petrucci A
    Neurol Sci; 2018 Feb; 39(2):329-332. PubMed ID: 29128986
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Miniature end-plate potentials at mammalian neuromuscular junctions poisoned by botulinum toxin.
    Spitzer N
    Nat New Biol; 1972 May; 237(70):26-7. PubMed ID: 4337978
    [No Abstract]   [Full Text] [Related]  

  • 19. Generalized botulism: diagnostic problems in a patient treated with botulinum toxin type A.
    Fota-Markowska H; Mitosek-Szewczyk K; Hasiec T
    Acta Ophthalmol Scand; 2007 Mar; 85(2):231-2. PubMed ID: 17305749
    [No Abstract]   [Full Text] [Related]  

  • 20. Botulinum toxin injection without electromyographic guidance in consecutive esotropia.
    Yang HK; Kim DH; Hwang JM
    PLoS One; 2020; 15(11):e0241588. PubMed ID: 33180838
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.